Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 941–960 of 17,529 recalls

November 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets

The Issue: Labeling: Label Error on Declared Strength; Some cartons

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 15, 2024· Evaric Pharmaceuticals Inc.

Recalled Item: Lisinopril Tablets

The Issue: Foreign Object Contamination

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· MXBBB

Recalled Item: UMARY ACID HYALURONIC

The Issue: Undeclared Diclofenac

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
November 14, 2024· Keystone Industries

Recalled Item: Gelato

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· Keystone Industries

Recalled Item: Henry Schein

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· Keystone Industries

Recalled Item: Quala Dental Products

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· Keystone Industries

Recalled Item: safco

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· Keystone Industries

Recalled Item: Dental City

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund
November 14, 2024· Keystone Industries

Recalled Item: Health-Tec

The Issue: CGMP deviations: the bulk product was rejected by

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardCompleted
Refund